Latest pharma updates on Drug Approvals

1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...

Read Full Story

Reach verified pharma buyers, suppliers & decision makers worldwide.

Connect with partners, startups & ventures driving the future of pharma.

Advertise on the fastest-growing B2B pharma marketplace.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.

PharmaTradz is your trusted B2B pharma platform connecting professionals across the industry.

Know More

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.